Calculate Your Salary Ranking
Home > Tranzyme Pharma Salary

Tranzyme Pharma Salary
  • 32
  • 43
  • 41

Tranzyme Pharma average salary is $260,000, median salary is $260,000 with a salary range from $260,000 to $260,000.
Tranzyme Pharma salaries are collected from government agencies and companies. Each salary is associated with a real job position. Tranzyme Pharma salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
260,000
Average
260,000
Median
260,000
High
260,000
Total 1 Tranzyme Pharma Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Sr Vice President, Research & Development 260,000-260,000 Durham, NC, 27701 2010 Tranzyme Pharma Sr Vice President, Research & Development Salaries (1)
Tranzyme Pharma Durham, NC Salaries
1
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Tranzyme Pharma Salaries (December 10, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Tranzyme Pharma salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Tranzyme Pharma Information
  • Tranzyme Pharma Inc
  • Industry: BioTech/Drugs
  • City: Durham, NC
  • Tranzyme, Inc. (Tranzyme) is a privately held biotechnology company engaged in the development of proprietary technologies for applied genomics, proteomics, and drug discovery. Tranzyme has developed proprietary molecular approaches in genetic engineering, gene transfer, and protein expression with broad applicability. The company¡¯s technology platform includes a unique protein expression technology (TExTTM), a proprietary gene transfer technology (TranzVectorTM), and a high-throughput screening and drug discovery technology (TranzAssayTM). Tranzyme¡¯s goal is to discover and develop new therapeutic lead compounds in partnership with other pharmaceutical and biotechnology companies. In addition, Tranzyme is focused on building an intellectual property portfolio of novel gene function(s)